Aggregation of amyloid peptides into fibrils driven by nanoparticles and their curvature effect

被引:8
|
作者
Li, Bin [1 ]
Zhang, Ran [2 ]
Shi, Xinghua [1 ,3 ]
机构
[1] Chinese Acad Sci, Lab Theoret & Computat Nanosci, CAS Key Lab Nanosyst & Hierarchy Fabricat, Natl Ctr Nanosci & Technol,CAS Ctr Excellence Nan, Beijing 100190, Peoples R China
[2] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Jilin, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
基金
中国国家自然科学基金;
关键词
PROTEIN AGGREGATION; KINETICS; FIBRILLATION; ALZHEIMERS; NUCLEATION; INHIBITION; SIMULATION; DISEASE; MODELS; GROWTH;
D O I
10.1039/c8cp07211f
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Fibrillation of amyloid peptides induces human diseases such as Alzheimer's disease, which has become a huge challenge. Some nanoparticles (NPs) could enhance peptide fibrillation by decreasing the lag time, yet how the size and shape of NPs affect amyloid fibrillation as well as the underlying mechanism remains unclear. Here, we investigated amyloid fibrillation on the surface of spherical NPs and cylindrical nanorods (NRs) of different sizes using coarse-grained Monte Carlo simulations. We focused on the curvature effect of NPs/NRs on the adsorption and fibrillation of peptide chains due to the size/shape difference. As the size of the NPs/NRs increases, the number of assembled peptide chains shows a non-monotonic tendency, and there is an optimal size for the highest adsorption. In most cases, the NRs could adsorb more peptides than the NPs of the same diameter due to the lower curvature. The mechanism beneath these observations was elucidated from a thermodynamic point of view. Our findings could provide a physical basis for the adsorption and fibrillation of amyloid peptides on NPs, and guide the design of future curvature-dependent NP-based amyloid treatment.
引用
收藏
页码:1784 / 1790
页数:7
相关论文
共 50 条
  • [41] Amyloid Fibrils: the Eighth Wonder of the World in Protein Folding and Aggregation
    Lednev, Igor K.
    BIOPHYSICAL JOURNAL, 2014, 106 (07) : 1433 - 1435
  • [42] High density lipoprotein inhibits assembly of amyloid β-peptides into fibrils
    Olesen, OF
    Dago, L
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (01) : 62 - 66
  • [43] A protein aggregation platform that distinguishes oligomers from amyloid fibrils
    Zhang, Amy
    Barron, Diana Portugal
    Chen, Erica W.
    Guo, Zhefeng
    ANALYST, 2023, 148 (10) : 2283 - 2294
  • [44] Thermodynamic properties of amyloid fibrils: A simple model of peptide aggregation
    Urbic, Tomaz
    Dias, Cristiano L.
    FLUID PHASE EQUILIBRIA, 2019, 489 : 104 - 110
  • [45] The diversity and utility of amyloid fibrils formed by short amyloidogenic peptides
    Al-Garawi, Zahraa S.
    Morris, Kyle L.
    Marshall, Karen E.
    Eichler, Jutta
    Serpell, Louise C.
    INTERFACE FOCUS, 2017, 7 (06)
  • [46] Using all-atom simulations in explicit solvent to study aggregation of amphipathic peptides into amyloid-like fibrils
    Jalali, Sharareh
    Yang, Yanxing
    Mahmoudinobar, Farbod
    Singh, Shaneen M.
    Nilsson, Bradley L.
    Dias, Cristiano
    JOURNAL OF MOLECULAR LIQUIDS, 2022, 347
  • [47] Design of a decapeptide for the inhibition of β-Amyloid aggregation and disaggregation the mature fibrils
    Zhi, Yuan
    Zhang, Qian
    Wang, Wei
    Liu, Jing
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [48] Snapshots of fibrillation and aggregation kinetics in multistranded amyloid β-lactoglobulin fibrils
    Bolisetty, Sreenath
    Adamcik, Jozef
    Mezzenga, Raffaele
    SOFT MATTER, 2011, 7 (02) : 493 - 499
  • [49] Amyloid-like fibrils of laminin-1 peptides
    Nomizu, M
    Kasai, S
    Ohga, Y
    Mochizuki, M
    Yamada, M
    Kadoya, T
    Nishi, N
    BIOPOLYMERS, 2003, 71 (03) : 376 - 376
  • [50] Amyloid-like fibrils of laminin-1 peptides
    Nomizu, Motoyoshi
    Kasai, Shingo
    Ohga, Yukiko
    Mochizuki, Mayumi
    Yamada, Masanori
    Kadoya, Yuichi
    Nishi, Norio
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 779 - 781